Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001327
Filing Date
2025-05-15
Accepted
2025-05-15 16:15:59
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20250331x10q.htm   iXBRL 10-Q 1238273
2 EX-31.1 snpx-20250331xex31d1.htm EX-31.1 10669
3 EX-31.2 snpx-20250331xex31d2.htm EX-31.2 10030
4 EX-32 snpx-20250331xex32.htm EX-32 16563
  Complete submission text file 0001410578-25-001327.txt   5453941

Data Files

Seq Description Document Type Size
5 EX-101.SCH snpx-20250331.xsd EX-101.SCH 48565
6 EX-101.CAL snpx-20250331_cal.xml EX-101.CAL 29768
7 EX-101.DEF snpx-20250331_def.xml EX-101.DEF 195431
8 EX-101.LAB snpx-20250331_lab.xml EX-101.LAB 373429
9 EX-101.PRE snpx-20250331_pre.xml EX-101.PRE 308475
63 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20250331x10q_htm.xml XML 661845
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 25953400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)